Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1675
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2489
    -0.0022 (-0.18%)
     
  • Bitcoin GBP

    50,993.48
    -581.23 (-1.13%)
     
  • CMC Crypto 200

    1,323.89
    -72.65 (-5.20%)
     
  • S&P 500

    5,109.83
    +61.41 (+1.22%)
     
  • DOW

    38,302.26
    +216.46 (+0.57%)
     
  • CRUDE OIL

    83.88
    +0.31 (+0.37%)
     
  • GOLD FUTURES

    2,345.20
    +2.70 (+0.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Why 2018 Could Be An Explosive Year For Biotech Mergers

Why 2018 Could Be An Explosive Year For Biotech Mergers

This year could be big for biotech mergers after Celgene and Sanofi, in a few days, spent $25 billion for three companies.